CMS Announces Automatic MIPS Exemption for Providers Affected by Natural Disasters
CMS announced it will allow automatic exemption from the 2025 MIPS for providers in certain Texas and California counties affected by natural disasters.
Read moreMain Content
ACR Congratulates Sirtex Medical on FDA Approval of Its SIR-Spheres to Treat Liver Cancer
The ACR-managed clinical trial was a key part of the approval effort.
Aug. 6, 2025
The ACR® Center for Research and Innovation (CRI®) served as the imaging contract research organization for the DOORwaY90 clinical trial that contributed to FDA approval of Sirtex SIR-Spheres technology for liver cancer treatment.
CRI’s management of image and data collection, quality control, and central review of 600 CT/MRI scans from 65 subjects across 12 sites using five expert reviewers was critical to the success of the trial.
Interim analysis of the DOORwaY90 trial revealed that 98.5% of patients had the Best Overall Response Rate through nine months and 100% of all evaluable patients were able to demonstrate local tumor control.
Related ACR News
Dangerous Scope of Practice Bills Fail in States
ACR advocates for proper supervision and interpretation of imaging exams by trained radiologists to ensure quality care.
Read moreSenate Proposes NIH Funding for FY 2026
Senate proposes $48.7B for NIH in FY 2026, with boosts to cancer and Alzheimer’s research. ACR and other groups urge stronger imaging R&D support.
Read more